rs2066518

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_014140.4(SMARCAL1):​c.1129G>C​(p.Glu377Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0198 in 1,613,744 control chromosomes in the GnomAD database, including 1,175 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. E377E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.035 ( 208 hom., cov: 33)
Exomes 𝑓: 0.018 ( 967 hom. )

Consequence

SMARCAL1
NM_014140.4 missense

Scores

5
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 5.67

Publications

22 publications found
Variant links:
Genes affected
SMARCAL1 (HGNC:11102): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1) The protein encoded by this gene is a member of the SWI/SNF family of proteins. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein shows sequence similarity to the E. coli RNA polymerase-binding protein HepA. Mutations in this gene are a cause of Schimke immunoosseous dysplasia (SIOD), an autosomal recessive disorder with the diagnostic features of spondyloepiphyseal dysplasia, renal dysfunction, and T-cell immunodeficiency. [provided by RefSeq, Jul 2008]
SMARCAL1 Gene-Disease associations (from GenCC):
  • Schimke immuno-osseous dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 2-216423665-G-C is Benign according to our data. Variant chr2-216423665-G-C is described in ClinVar as Benign. ClinVar VariationId is 198202.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.149 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCAL1NM_014140.4 linkc.1129G>C p.Glu377Gln missense_variant Exon 6 of 18 ENST00000357276.9 NP_054859.2
SMARCAL1NM_001127207.2 linkc.1129G>C p.Glu377Gln missense_variant Exon 6 of 18 NP_001120679.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCAL1ENST00000357276.9 linkc.1129G>C p.Glu377Gln missense_variant Exon 6 of 18 2 NM_014140.4 ENSP00000349823.4

Frequencies

GnomAD3 genomes
AF:
0.0351
AC:
5346
AN:
152152
Hom.:
210
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0745
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0130
Gnomad ASJ
AF:
0.0216
Gnomad EAS
AF:
0.158
Gnomad SAS
AF:
0.0684
Gnomad FIN
AF:
0.00829
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.00964
Gnomad OTH
AF:
0.0335
GnomAD2 exomes
AF:
0.0323
AC:
8121
AN:
251456
AF XY:
0.0324
show subpopulations
Gnomad AFR exome
AF:
0.0738
Gnomad AMR exome
AF:
0.00942
Gnomad ASJ exome
AF:
0.0230
Gnomad EAS exome
AF:
0.157
Gnomad FIN exome
AF:
0.0111
Gnomad NFE exome
AF:
0.0102
Gnomad OTH exome
AF:
0.0236
GnomAD4 exome
AF:
0.0182
AC:
26634
AN:
1461474
Hom.:
967
Cov.:
30
AF XY:
0.0194
AC XY:
14134
AN XY:
727078
show subpopulations
African (AFR)
AF:
0.0753
AC:
2518
AN:
33456
American (AMR)
AF:
0.00982
AC:
439
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0229
AC:
599
AN:
26130
East Asian (EAS)
AF:
0.161
AC:
6404
AN:
39696
South Asian (SAS)
AF:
0.0637
AC:
5496
AN:
86232
European-Finnish (FIN)
AF:
0.0102
AC:
544
AN:
53378
Middle Eastern (MID)
AF:
0.0560
AC:
323
AN:
5764
European-Non Finnish (NFE)
AF:
0.00781
AC:
8677
AN:
1111716
Other (OTH)
AF:
0.0271
AC:
1634
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
1358
2716
4074
5432
6790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0351
AC:
5341
AN:
152270
Hom.:
208
Cov.:
33
AF XY:
0.0365
AC XY:
2721
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0744
AC:
3091
AN:
41544
American (AMR)
AF:
0.0129
AC:
197
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
75
AN:
3466
East Asian (EAS)
AF:
0.158
AC:
821
AN:
5182
South Asian (SAS)
AF:
0.0678
AC:
327
AN:
4824
European-Finnish (FIN)
AF:
0.00829
AC:
88
AN:
10616
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.00966
AC:
657
AN:
68020
Other (OTH)
AF:
0.0331
AC:
70
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
248
496
745
993
1241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0175
Hom.:
22
Bravo
AF:
0.0371
TwinsUK
AF:
0.00701
AC:
26
ESP6500AA
AF:
0.0783
AC:
345
ESP6500EA
AF:
0.00907
AC:
78
ExAC
AF:
0.0333
AC:
4040
Asia WGS
AF:
0.104
AC:
362
AN:
3478
EpiCase
AF:
0.0110
EpiControl
AF:
0.0117

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Schimke immuno-osseous dysplasia Benign:5
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 01, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:4
Oct 21, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:3
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27884173, 17089404, 25748404, 20981092)

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Focal segmental glomerulosclerosis Benign:1
Sep 27, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.021
T;T;T;T
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.46
LIST_S2
Benign
0.0
.;D;D;T
MetaRNN
Benign
0.0017
T;T;T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Uncertain
2.6
M;M;.;.
PhyloP100
5.7
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.1
N;N;N;N
Sift
Benign
0.068
T;T;T;D
Sift4G
Uncertain
0.041
D;D;T;D
Vest4
0.083
ClinPred
0.025
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.22
gMVP
0.42
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.31
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.31
Position offset: 18

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066518; hg19: chr2-217288388; COSMIC: COSV61921231; COSMIC: COSV61921231; API